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Abstract
Neuronal communication (synaptic transmission) is critical for nervous system function.
This communication occurs at specialized junctions called synapses where chemical
neurotransmitters signal from presynaptic to postsynaptic cells. Additional signaling via
neuropeptide activated G protein-coupled receptors (GPCRs) fine-tunes synaptic
communication. GPCRs are a large family of transmembrane receptor proteins that bind
extracellular neurotransmitters and neuropeptides to activate intracellular signaling
pathways. My project investigated the function of FSHR-l, a GPCR and potential
neuropeptide receptor, in regulating synaptic transmission at the neuromuscular junction
(NMJ) in Caenorhabditis elegans roundworms, which share conservation of nervous
system structure and function with humans. Worms lacking the fshr-I gene have reduced
muscle contraction at the NMJ; however, the mechanism by which FSHR-l controls
signaling at this synapse is unknown. I hypothesized that FSHR-l is a neuropeptide
receptor for one or more unknown neuropeptides that acts in presynaptic motor neurons
to modulate NMJ transmission. Initial genetic and behavioral analyses of/shr-l and
neuropeptide signaling mutants indicate that.f~·hr-l does not interact with neuropeptide
signaling; however future studies are needed to fully explore a potential interaction. With
regard to downstream targets of FSHR-l signaling at the NMJ, behavioral results indicate
that the adenylyl cyclase enzyme ACY -1, may work in the same signaling pathway as
FSHR-l to control muscle contraction. I currently am exploring other downstream targets
of FSHR-l, as well as quantifying synaptic vesicles in cholinergic and GABAergic motor
neurons ofJshr-1 mutants using imaging techniques. To date, I have found that there is
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an increase in synaptic vesicle accumulation in presynaptic cholinergic motor neurons in
fshr-I mutants suggestive of decreased synaptic vesicle release from these cells. Together
these results provide information regarding the potential neuronal function of FSHR -1 in
synaptic transmission, which may provide insight into human neurological diseases that
involve in altered neurotransmission.
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Chapter 1: Introduction to FSHR-l as a critical G protein-coupled
receptor in C. elegans
Neuronal Signaling and Regulation
Our body is controlled by the nervous system. Information is received by our
senses, processed in the brain and sent back out to control the function of muscles and
glands. The circuitry of this communication network is composed of neurons that connect
at junctions called synapses. It is at these synapses that chemical signaling (synaptic
transmission) occurs in which small molecules travel across the synaptic cleft to relay
information from the presynaptic ("sending") neuron to the postsynaptic ("receiving")
neuron (Figure 1-1). Specifically, neurotransmitters (the chemical signals) are released
from the presynaptic neuron upon arrival of an electrical signal (action potential) in the
axon terminus of that neuron. The neurotransmitters then cause an excitatory or
inhibitory response in the postsynaptic neuron by binding to receptors on that cell. This
binding can cause either further transmission of the signal (excitation) or can prevent the
signal from spreading (inhibition) into the postsynaptic cell (Sherwood, et al. 2005).
Regulation of excitatory and inhibitory synaptic transmission is critical, as a
balance between the two allows for normal neuronal function. There are hundreds of
synaptic proteins that reside at presynaptic and postsynaptic sites, but how they directly
regulate excitatory and/or inhibitory synaptic transmission is not fully understood (Yi and
Ehlers 2005). Moreover, misregulation of synaptic signaling is among the initial effects
9
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Figure 1-1. A Synapse. Diagram of two neurons creating a synaptic connection.
Enlarged view of the synapse.
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of neurodegenerative disorders such as Parkinson's disease or Alzheimer Disease, as well
as neurological disorders such as epilepsy and mental retardation (Ardley, et a1. 2005).
Thus, understanding the factors involved in controlling signaling at neuronal synapses is
important for being able to better treat these disorders.
G Protein-Coupled Receptors Contribute to the Regulation of Neuronal Signaling
There are different types of receptors in the nervous system that help to propagate
electrical signals and modulate chemical signals at synapses. Some of these receptors,
which are activated in response to ligand binding, include various types of ligand-gated
ion channels, which allow the passage of positively or negatively charged ions in and out
of the cell, and G Protein-coupled receptors (GPCRs), which initiate a cascade of
downstream intracellular signaling events (Figure 1-2).
GPCRs are seven-pass transmembrane receptors known to activate intracellular
heterotrimeric G proteins composed of alpha, beta, and gamma subunits. GPCRs are
activated by interaction between a ligand and the GPCR, leading to separation of the beta
and gamma subunits of the G protein from the alpha subunit, which is activated by the
exchange ofGTP in place ofGDP. There are four main types ofG protein pathways,
which are classified by the effects of the alpha subunit, that may be activated by these
GPCRs: Gccq (EGL-30), Gal2 (GPA-12), Gao (GOA-I), and Gas (GSA-I) (Perez-
Mansukka and Nurrish, 2009). Specific ligands for GPCRs can include hormones,
neurotransmitters, neuropeptides (which fine-tune neuronal signaling), pheromones,
cytokines, and many others types of molecules (Tatsuya and Bernstein, 2000). The
diverse functions of GPCRs make these receptors important drug targets when it comes
11
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Figure 1-2. G protein-Coupled Receptor Signaling. GPCRs are transmembrane
receptors that can interact with neuropeptides or other ligands to activate downstream
signaling pathways. One common pathway initiated by many GPCRs involves activation
of an adenylyl cyclase enzyme by GTP-bound Ga subunits following ligand-GPCR
binding. Adenylyl cyclase generates cyclic AMP (cAMP) second messengers, which in
turn activate effector kinases such as protein kinase A (PKA).
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to treating pain, hypertension, schizophrenia, and asthma (Hill, 2009). Given the large
number of GPCRs in the nervous system (Hill, 2009), it is likely that even more GPCRs
will be targets of future drugs for a wide range of neurological disorders.
C. elegans are a Model System for Investigating Neuronal Function
Given the complexity of the human nervous system, I use e elegans roundworms
to study questions related to the control of synaptic transmission in Dr. Kowalski's lab.
e elegans are excellent animals in which to perform these studies because there are
many similarities between the human and e elegans nervous systems, particularly in
terms of their protein composition and function and the basic circuitry of the nervous
system. However, the e elegans nervous system is less complex than that of humans,
and all of the synaptic connections are known (White, et al. 1986). These worms also
have a set of simple behaviors, allowing for easy manipulation and measurement of
synaptic transmission through straightforward behavioral assays. In addition, C. elegans
have short life cycles of approximately 3-4 days that allow for easy breeding and
manipulation, making them excellent for the genetic studies I performed.
C. elegans Neuromuscular Junction as Model Synapse
Our lab uses the C. elegans neuromuscular junction (NMJ) as a model synapse for
studying synaptic transmission (Figure 1-3). The NMJ is the synapse between a
presynaptic neuron and a postsynaptic muscle cell, which ultimately controls muscle
contraction. Muscle activity at the C. elegans NMJ is controlled by a balance of
excitatory (acetylcholine) signaling, which causes action potentials in the postsynaptic
13
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Figure 1-3. The nervous system of C. elegans with enhanced schematic of the NMJ.
At the NMJ, motor neurons communicate with muscle cells. There are two types of motor
neurons, GABAergic and cholinergic. Cholinergic motor neurons release acetylcholine
producing an excitatory response in the postsynaptic muscle cells that promotes muscle
contraction. GABAergic motor neurons release GABA producing an inhibitory response
on the postsynaptic muscle cells that prevents contraction. A balance of inhibitory and
excitatory signals allows for proper muscle contraction and relaxation, which are
necessary for movement of the animal.
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cell leading to muscle contraction, and inhibitory (GABA) signaling that promotes
inhibition of action potentials in the postsynaptic cell restricting muscle contraction
(Richmond and Jorgensen 1999). The amount of signaling for muscle contraction can be
measured by a behavioral assay using a chemical called aldicarb (Mahoney et al, 2006).
Aldicarb is a reversible acetylcholinesterase inhibitor. Acetylcholinesterase is found in
the synaptic cleft of the NMJ in C. elegans and works to break down the neurotransmitter
acetylcholine (ACh); thus acetylcholinesterase works to shut off muscle contraction at the
NMJ. Exposing worms to aldicarb causes paralysis due to muscle hypercontraction that
results from the accumulation of acetylcholine in the synaptic cleft (Mahoney, et al.
2006). Worms that have mutations that cause an increase in synaptic transmission
paralyze faster than wild type worms and are thus aldicarb-hypersensitive. The opposite
is true, as well: worms that have mutations that cause a decrease in synaptic transmission
are resistant to aldicarb, paralyzing more slowly than wild type animals (Mahoney, et al.
2006) (Figure 1-4). The aldicarb assay has been used extensively by Dr. Kowalski's lab,
as well as others, to identify genes involved in synaptic transmission at the NMJ
(Sieburth, et al. 2005; Vashlishan, et al. 2008).
FSHR-1 is a GPCR that Regulates Signaling at the c. elegans NMJ
My research focused on the role of one gene,fshr-l, that is required for normal
NMJ signaling and the mechanisms by which it affects synaptic transmission at the C.
elegans NMJ. FSHR-l is a GPCR that is required for innate immune responses and
germ line differentiation in C. elegans (Cho, et al. 2007; Powell, et al. 2009).fshr-l loss
of function mutants also exhibit increased resistance to aldicarb compared to wild type
15
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Figure 1-4. Schematic of the aldicarb assay for synaptic transmission at the NMJ.
Possible aldicarb assay outcomes. Worms with mutations that cause an increase in
muscle excitation will paralyze faster than wild type worms in the presence of aldicarb,
an acetylcholinesterase inhibitor. Worms with mutations causing a decrease in muscle
excitation will paralyze more slowly.
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animals (Sieburth, et al. 2005), and current students working in Dr. Kowalski's lab have
identified FSHR -1 as a possible substrate of the Anaphase Promoting Complex (APC)
enzyme, another regulator ofNMJ signaling (unpublished data).
FSHR-1 is the only C. elegans protein similar to the receptors for follicle
stimulating, thyroid stimulating, and luteinizing hormone in mammals (Cho, et al. 2007);
in addition, recent research has suggested that FSHR -1 may function as a neuropeptide
receptor (Sieburth, et al. 2005). A recent study demonstrated that the Gas pathway,
which includes gsa-l (Gas) and acy-l (adenylyl cyclase), is activated downstream of
FSHR -1 in germline differentiation; however, nothing is known about pathways FSHR-1
activates in neurons (Cho, et al. 2007). Thus, two main goals of my project were to test
the potential role of FSHR-l involvement in signaling pathways with neuropeptides and
to determine the downstream signaling pathways FSHR-l activates to control NMJ
transmission for muscle contraction.
Several lines of evidence suggest that FSHR-l may control NMJ signaling in
C. elegans by functioning presynaptically in motor neurons. First, FSHR-l expression is
not seen in muscle, but rather occurs at high levels in the intestines and neurons of C.
elegans (Cho, et al. 2007). Second, animals lackingf~'hr-l exhibit increased accumulation
of synaptic vesicle associated proteins, indicative of decreased synaptic vesicle release, in
cholinergic neurons (Sieburth, et al. 2005). However, whether FSHR-I affects synaptic
vesicle localization in GABA neurons or whether FSHR-l function is specifically
required in either cholinergic or GABAergic motor neurons to elicit the decreased muscle
excitation seen infshr-l mutants, has not been tested. My project also investigates the
localization of synaptic vesicles in presynaptic GABAergic and cholinergic motor
17
neurons infshr- 1 mutants through quantitative imaging of fluorescently tagged synaptic
vesicle proteins.
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Thesis Statement
Based on data from previous studies, including the high expression oifshr-l in
neurons, its effects on synaptic vesicle release in cholinergic neurons, and its apparent
ability to signal through the Gas pathway to regulate germline differentiation, I
hypothesized thatf~'hr- 1 is a neuropeptide receptor that acts in presynaptic motor neurons
by signaling through the Gas pathway to control the release of cholinergic and/or
GABAergic synaptic vesicles to promote muscle contraction at the NMJ. In the following
chapters, I will describe the genetic, behavioral, and molecular experiments I completed
to begin characterizing the upstream and downstream targets in signaling pathways
FSHR-l is affecting to control muscle contraction at the NMJ.
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Chapter 2: Investigation of FSHR-l involvement in neuropeptide
signaling at the NMJ
Note of Clarification
The following experiments were performed by 1. Kolnik. Continued work on the
behavioral studies will be carried out by another labmate, A. Munneke. Strains were
obtained from the Caenorhabditis Genetics Center at the University of Minnesota,
Background
Neuropeptides are short sequences of amino acids that can function directly or
indirectly to modulate synaptic transmission. There are over 250 neuropeptides identified
to date that function at synaptic clefts (Li and Kim 2008). Neuropeptides can be
categorized into three different families: insulin-like peptides, FMRFamide-related
pep tides (FLPs), and non-insulin, non-FLP peptides, called neuropeptide-like proteins
(NLPs) (Li and Kim 2008). Neuropeptide receptors are most often G protein-coupled
receptors (GPCRs). Neuropeptides may auto-regulate presynaptic neurons by modulating
the amount of neurotransmitters released into the synaptic cleft (Li and Kim 2008).
Neuropeptides also can regulate postsynaptic neurons by modulating the number and type
of neurotransmitter receptors present on neuronal cells (Li and Kim 2008).
C elegans fshr-l loss of function mutants are aldicarb-resistant, indicating a
reduction in signaling for muscle contraction, and previous studies have suggested that
FSHR-l may be acting as a neuropeptide receptor to regulate NMJ signaling (Sieburth, et
al. 2005). Other studies have shown that worms lacking the function of essential
21
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neuropeptide processing and release genes also are aldicarb-resistant (Jacob and Kaplan
2003), suggesting a model in which these genes act in the same pathway with FSHR-l at
the NMJ. These neuropeptide-related genes include egl-21 and egl-3, both of which
encode proteins that are expressed in the nervous system and are known neuropeptide
processing enzymes that appear to act on different subsets of FLP and NLP neuropeptides
(Husson et al, 2006; Husson et al, 2007). Recent research demonstrates that mutant
worms deficient in egl-21 or egl-3 exhibit a resistant aldicarb phenotype compared to
wild-type worms, which is indicative of decreased muscle contraction (Jacob and Kaplan,
2003). This may be due to a decrease in acetylcholine signaling or an increase in GABA
signaling, or both, in these mutants. The mechanism by which this is occurring, how egl-
21 and egl-3 are modulating synaptic transmission through neuropeptide processing, is
still unknown. Additionally, NLP-12, a neuropeptide known to work at the NMJ and part
of the NLP class ofneuropeptides processed by egl-3 and egl-21 (Jacob and Kaplan,
2003), may be a ligand that binds to FSHR -1 to initiate a downstream pathway important
for muscle contraction. nlp-12 was identified as being required for NMJ signaling in the
same study that first identified FSHR-l as an NMJ regulator (Hu et aI, 2011) .
To test whether FSHR-l and neuropeptides act in the same pathway to control
muscle contraction, I generatedfshr-l;egl-21 andj~'hr-l;nlp-12 double loss of function
mutants and tested these animals in the aldicarb assay relative to wild type worms and to
each single mutant. If FSHR-l and neuropeptide signaling are required in the same
pathway to regulate muscle contraction at the NMJ, then animals lacking both
neuropeptide signaling and FSHR-l should show a non-additive phenotype in the
aldicarb assay. A non-additive phenotype would be one in which the aldicarb-resistance
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for a double mutant is not stronger than the strongest single mutant phenotype. If instead,
FSHR-l and neuropeptides control muscle contraction independently, then animals
lacking both genes should have a stronger aldicarb resistance than animals lacking only
one or the other, showing an additive relationship (Figure 2-1).
Materials and Methods
C. elegans strain maintenance
Strains used in this experiment included N2 (Bristol), egl-2i (n4 76), nlp-12
(ok335), andfshr-i (ok778). All strains were obtained from the Caenorhabditis Genetics
Center at the University of Minnesota. Worms were kept in a 20°C environment on NGM
agar medium with OP50 E. coli as a food source and maintained according to standard
procedures (Brenner, 1974).
egl-2i strain generation
In order to generate egl-2i,fshr-i double mutants, 15 N2 males were mated with 5
egl-2i hermaphrodites. Next, fifteen male progeny of this cross were picked onto another
plate, along with 5fshr-i hermaphrodites. After one generation, twelve hermaphrodites
were singled onto separate plates. One generation later, PCR genotyping was used to
confirm the presence of the n476 and ok778 alleles as described below. Next, twenty
worms from a plate that contained a heterozygote parent at both loci, were singled onto
new plates and allowed to grow for one generation to identify the homozygous mutant
23
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Figure 2-1. Genetic analysis of FSHR-l and neuropeptide pathways. Neuropeptides
and FSHR-l may be working in the in the same pathway or different pathways to
promote muscle contraction. If they function in the same pathway, their mutants should
have non-additive effects in the aldicarb assay. If they function through different
pathways, their mutants should have additive phenotypes in the aldicarb assay.
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genotypes in the next generation. The egl-21 (n476),fshr-l (ok 778) double mutant was
given a strain name (JRK26) and stored as a frozen stock.
nlp-12 strain generation
In order to generate nlp-12,fshr-l double mutants, 15 N2 males were mated with
5 nlp-12 hermaphrodites. These animals then grew for one generation. Next, fifteen male
progeny were picked onto another plate, along with 5 fshr-I hermaphrodites. After one
generation, twelve hermaphrodites were singled onto separate plates. One generation
later, PCR genotyping was used to confirm the presence of the ok335 and ok778 alleles as
described below. Then twenty worms from a plate that contained a heterozygote parent at
both loci were singled onto new plates and allowed to grow for one generation to identify
the homozygous mutant genotypes in the next generation. The nlp-12(ok335),jshr-
1(ok778) double mutant was given a strain name (JRK41) and stored as a frozen stock.
Lysis and peR
DNA extracts were made according to the following protocol. Twenty worms from each
plate were added to a mixture of worm lysis buffer (50mM KCl, 10mM Tris pH 8.3,
2.5mM MgCb, 0.45% Tween20, 0.45% NP40) and 200~lg/mL protease K. These samples
were frozen at -80°C for 15 minutes. Following this, the samples were heated for 60
minutes at 60°C, and then for 15 minutes at 95 °C in a thermo cycler. Two and half ~tlof
each lysate were used as a template in a PCR reaction, along with l x Taq buffer, 0.2mM
dNTPs, O.Spmol/u.L forward primer, 0.5pmol/~lL reverse primer, deionized water, and
Taq polymerase (gift of Dr. R.J. Johnson, Butler Department of Chemistry). The PCR
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temperature cycling protocol consisted of one cycle of 2 minutes at 94°C, thirty cycles
repeating a sequence of 1 minute at 94 °C, 1:30 minutes at 55°C, and 3 minutes at 72 °C,
followed by one cycle of 7 minutes at 72°C.
fshr-l (ok778) genotyping
fshr-l-REV (CCTCCCCCATCACTCTTTTT) andfshr-l-FWD
(TGTAGGCTCGTGT ACTCCCC) primers were used. The final PCR product size was
3000 base pairs for the wild-type bands and 500 base pairs for the mutant bands.
Following PCR, gel electrophoresis was performed. Gels made of 1% agarose in TBE
and one drop of ethidium bromide were run with these samples, and samples indicating
mutant band sizes for fshr-l were selected as they represented a homozygote at that
locus.
egl-21 (n476) genotyping
n476-REV (GCTCGCCAAGGAGGAATTAC) and n476-FWD
(CGTTTCTTTCACGTCCGCTC) primers were used. The PCR product acted as the
lysate template again adding two and half ul for a second round of PCR using inner
primers n476-REV-B (GCTCAAAGACAATGGCTCAC) and n476-FWD-B
(GGAAA TGAGCCAATCGGAAG). Final PCR product size was 239 base pairs for the
wild-type bands and 195 base pairs for the mutant bands. Following PCR, gel
electrophoresis was performed. Gels made of 2% agarose in TBE and one drop of
ethidium bromide were run with these samples, and samples indicating mutant band sizes
for egl-21 were selected as they represented a homozygote at that locus.
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nlp-i2(ok335) genotyping
nlp-i2-REV (CCTCCCCCATCACTCTTTTT) and nlpi2-FWD
(TGTAGGCTCGTGT ACTCCCC) primers were used. The final PCR product size was
1500 base pairs for the wild-type bands and 500 base pairs for the mutant bands.
Following PCR, gel electrophoresis was performed. Gels made of 1% agarose in TBE
and one drop of ethidium bromide were run with these samples, and samples indicating
mutant band sizes for nlp-I Z were selected as they represented a homozygote at that
locus.
Aldicarb Assay
Twelve aldicarb plates were made at a concentration of ImM aldicarb in NGM
agar one day before the experiment. Plates were poured and left open for two hours at
room temperature to solidify, then spotted with OP50 E. coli and left open for
approximately one more hour to fully dry. Plates were then covered and left at room
temperature overnight. The next day, approximately 20 young adult worms were picked
to each ofthree plates per strain, with a total of 12 plates the day of the assay. Worms
were then transferred from these 12 plates onto the experimental aldicarb plates in two-
minute time intervals. Beginning 40 minutes after plating, the worms were tapped on the
nose twice with a platinum wire every 25 minutes to determine if paralysis had occurred.
Results were recorded every 25 minutes until two-thirds or more of the worms were
completely paralyzed. The results were graphed so that the average percentage of worms
27
paralyzed ± s.e.m. at each timepoint was represented. Experiments were performed at
least three times for all genotypes.
Results
egl-2I,fshr-I double mutants showed an additive effect in the aldicarb paralysis
assay, in which the phenotype of the double mutant was more severe than that of either
egl-2I orfshr-I single mutants (Figure 2-2) . This indicates thatfshr-l is not working in
the same genetic pathway as egl-2I to control muscle contraction at the NMJ.
Additionally, nlp-I2,fshr-I double mutants showed an additive aldicarb phenotype
(Figure 2-3) . Therefore it does not appear thatfthr-I is working in the same genetic
pathway as nlp-I2.
Discussion
The aldicarb paralysis results indicate that egl-21 is not working in the same
genetic pathway zsfshr-l tuie to the additive phenotype ofthefshr-l;egl-2I double
mutants seen in all three aldicarb assays (Figure 2-2). egl-2I is one of a few neuropeptide
processing enzymes that work at the NMJ, specifically on FLP and NLP classes of
neuropeptides (Husson et al, 2007). egl-3 is another neuropeptide processing enzyme that
also works at the NMJ on FLP and NLP neuropeptides (Husson et al, 2006); however,
egl-21 and egl-3 loss of function mutants have additive effects at the NMJ suggesting that
they process different subsets of neuropeptides (Jacob and Kaplan 2003). Thus, to further
test whether FSHR -1 is working in a neuropeptide pathway, I am in the process of
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Figure 2-2. egl-Zl ifshr-I double mutants show additive effects in the aldicarb assay.
Average paralysis of four strains of C elegans for an aldicarb assay. N2 (wild type)
worms,fshr-l(ok778) mutants, egl-21 (n476) mutants, and egl-21,:fshr-l double mutants
were tested for paralysis in response to aldicarb. Worms were exposed to plates
containing 1mM aldicarb over a three hour time period. 20 young adult worms of each
strain (3 plates per strain) were tested for paralysis at time points taken every 25 minutes.
Error bars show the standard error of the mean.
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Figure 2-3. nlp-Tlifshr-I double mutants show additive effects in the aldicarb assay.
Average paralysis of four strains ofC elegans for an aldicarb assay. N2 (wild type)
worms,fshr-l(ok778) mutants, nlp-12 mutants, and nlp-Tl.fshr-I double mutants were
tested for paralysis in response to aldicarb. Worms were exposed to plates containing
1mM aldicarb over a three hour time period. 20 young adult worms of each strain (3
plates per strain) were tested for paralysis at time points taken every 25 minutes. Error
bars show the standard error of the mean.
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generating both egl-Bfshr-I double mutants, as well as a triple mutant, egl-3fshr-l;egl-
21;, Unfortunately, it is particularly difficult to generate fshr-I egl-3 mutants due to the
fact that egl-3 andfshr-l are located relatively close to each other on the same
chromosome, making it difficult for recombination to occur, Upon completion of these
crosses, however, I would again test the phenotype of these double and triple mutants for
additivity in the aldicarb assay to determine the possible role FSHR-l might be playing in
neuropeptide signaling.
My aldicarb data also suggest that nlp-12 is not working in the same genetic
pathway asfshr-l (Figure 2-3). Although nlp-12,fshr-1 double mutants demonstrated an
additive phenotype in aldicarb assays, it does not confirm thatfshr-l does not work in a
neuropeptide pathway. nlp-12 is only one of over 250 neuropeptides that may work at the
NMJ to modulate neurotransmission (Sieburth et al, 2005). Thus, there are many other
possible neuropeptide ligands for FSHR-l that could be tested in future studies. As stated
before, nlp-I Z was chosen as a candidate because it has been identified to work at the
NMJ (Hu et al, 2011). Future work using other neuropeptides that have been identified in
the Sieburth et al. (2005) screen can be tested as other possible neuropeptides that may be
acting as a ligand for activation ofFSHR-l at the NMJ.
FSHR-l is a known GPCR that could be acting as a neuropeptide receptor that
modulates neuropeptide release. To further investigate the interaction of FSHR-l with
neuropeptides, I could image fluorescently tagged neuropeptides infshr-l mutants to
visualize any potential alterations in their localization in the dorsal nerve cord compared
to wild type worms.
31
r ,.
References
Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics. 77: 71-94.
Hu, Z. et al. 2011. A Neuropeptide-Mediataed Stretch Response Links Muscle
Contraction to Changes in Neurotransmitter Release. Neuron. 71: 92-102.
Husson, S. 2006. Defective processing of neuropeptide precursors in Caenorhabditis
elegans lacking proprotein convertase 2 (KPC-2/EGL-3): mutant analysis by mass
spectrometry. Journal of Neurochemistry. 98: 1999-2012.
Husson, S. 2007. Impaired processing of FLP and NLP peptides in carboxypeptidase E
(EGL-21 )-deficient Caenorhabditis elegans as analyzed by mass spectrometry.
Journal ofNeurochemistry, 102: 246-260.
Jacob, T.C., Kaplan, 1.M. 2003. The EGL-21 Carboxypeptidase E Facilitates
Acetylcholine Release at Caenorhabditis elegans Neuromuscular Junctions. The
Journal of Neuroscience. 23: 2122-2130.
Li, C., Kim, K. 2008. Neuropeptides. The C. elegans Research Community, Worm Book.
Doi/10.l895/wormbook.1.142.1. http://www.wormbook.org.
Sieburth, D. et al. 2005. Systematic analysis of genes required for synapse structure and
function. Nature. 436:510-517.
32
--
Chapter 3: Investigation of signaling pathways activated downstream of
FSHR-l to control NMJ function
Note of Clarification
The following experiments were performed by J. Kolnik with the exception of the
aldicarb assays testing the acy-Ltfshr-I double mutants, which were performed by
another labmate, A. Munneke, under the supervision of J. Kolnik. Strains were obtained
from the Caenorhabditis Genetics Center at the University of Minnesota.
Background
It has been shown that loss of function mutants for the GPCR FSHR-l are
resistant to aldicarb-induced paralysis, demonstrating thatfi'hr-I is necessary for normal
synaptic transmission at the NMJ (Sieburth, et al. 2005). In a previous study investigating
the role of FSHR-l in germline differentiation, the Gas pathway was shown to be
involved downstream of FSHR-l (Cho, et al. 2007). Specifically, gain of function
mutations in Gas (gsa-I) or another downstream enzyme in the pathway, adenylyl
cyclase (acy-I), were able to rescue defects in germline differentiation caused by loss of
fshr-I function (Cho, et al. 2007). Moreover, loss of function of either gsa-I and acy-l
causes decreased synaptic transmission (aldicarb resistance) as does loss offshr-I
(Sieburth, et al. 2005), whereas gain of function mutants in acy-l and gsa-I are aldicarb-
hypersensitive (Cho et al, 2007). Thus, I hypothesized thatfshr-Iacts through this G
protein pathway to regulate NMJ signaling.
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I tested this hypothesis by generating a series of double mutants containing both
loss of functionzc/v-? mutations and gain of function mutations in these G protein
pathway genes ifshr-I ;gsa-l (gf) andfshr-l ;acy-l (gf)] , which I then tested for their
sensitivity relative to wild type and single mutant animals to aldicarb-induced paralysis.
Iffshr-l and gsa-lor acy-l function in the same pathway to control muscle contraction,
then the gsa-lor acy-l phenotype should overcome the fshr-l loss of function phenotype
so that the double mutant looks like the gsa-lor acy-l single mutant. However, an
intermediate aldicarb phenotype that represents the sum of the effects of the aldicarb
resistance induced by fshr-l loss of function and the aldicarb hypersensitivity of gsa-l
and acy-l gain of function mutants should occur iffshr-l and gsa-lor acy-l work in
independent pathways at the NMJ.
Methods and Materials
C. elegans strain maintenance
Strains used in this experiment included N2 (Bristol), gsa-l (ce81), acy-l
(md1756), andfs'hr-l (ok778). All strains were obtained from the Caenorhabditis Genetics
Center at the University of Minnesota. Worms were kept in a 20°C environment on NGM
agar medium and maintained according to standard procedures (Brenner, 1974).
gsa-l strain generation
In order to generate gsa-l ,fshr-l double mutants, 15 N2 males were mated with 5
gsa-l hermaphrodites. These animals then grew for one generation. Next, fifteen male
progeny were picked onto another plate, along with 5 fshr-l hermaphrodites. After one
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generation, twelve hermaphrodites were singled onto separate plates. One generation
later, PCR genotyping was used to confirm the presence of the ce8l and ok778 alleles as
described below. Then twenty worms from a plate that contained a heterozygote parent at
both loci were singled onto new plates. These animals were allowed to grow for one
generation to verify the homozygous mutant genotypes in the next generation.
acy-l strain generation
In order to generate acy-l,:fshr-l double mutants, 15 N2 males were mated with S acy-l
hermaphrodites. These animals then grew for one generation. Next, fifteen male progeny
were picked onto another plate, along with 5 fshr-l hermaphrodites. After one
generation, twelve hermaphrodites were singled onto separate One generation later, PCR
genotyping was used to confirm the presence of the mdl756 and ok778 alleles as
described below. Then twenty worms from a plate that contained a heterozygote parent at
both loci were singled onto new plates. These animals were allowed to grow for one
generation to verify the homozygous mutant genotypes in the next generation. The acy-
l (mdI756),:fshr-1 (ok778) double mutant was given a strain name (JRKS5) and stored as a
frozen stock.
Lysis and peR
DNA lysates were made according to the following protocol. Twenty worms from each
plate were added to a mixture of worm lysis buffer (SOmM KCI, 10mM Tris pH 8.3,
2.5mM MgCh, 0.45% Tween20, 0.45% NP40) and 200~lg/mL protease K. These samples
were frozen at -80°C for 15 minutes. Following this, the samples were heated for 60
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minutes at 60 DC,and then for 15 minutes at 95 DCin a thermo cycler. Two and half ul of
each lysate were used as a template in a PCR reaction, along with lx Taq buffer, 0.2mM
dNTPs, 0.5pmoll~tL forward primer, 0.5pmolhtL reverse primer, deionized water, and
Taq polymerase (gift of Dr. R.J. Johnson, Butler Department of Chemistry). The PCR
temperature cycling protocol consisted of one cycle of 2 minutes at 94 DC,thirty cycles
repeating a sequence of 1minute at 94 DC, 1:30 minutes at 55 DC,and 3 minutes at 72 DC,
followed by one cycle of 7 minutes at 72 DC.
gsa-i (ce8i) genotyping
gsa-i-REV (GAGACGCAGAGAGTTCTTAACTG) and gsa-I-FWD
(CAAATCGGCAAA TCGGCAAA) primers were used. The PCR product acted as the
lysate template again adding two and half ul for a second round of PCR using inner
primers gsa-I-REV-B (CTTTCGGCTTGATCTACGTTG) and gsa-I-FWD-B
(CGATCACATTCTCACTTGCTG). Final PCR product size was 850 base pairs for the
mutant bands. Following PCR, gel electrophoresis was performed. Gels made of 1%
agarose in TBE and one drop of ethidium bromide were run with these samples, and
samples indicating mutant band sizes for gsa-I were selected as they represented a
homozygote at that locus. To sequence, the DNA as run through a gel purification kit
(Qiagen). 1ul of purified DNA was added to 5~tl of forward diluted (Spmol/ul)
sequencing primer (TTGCTGGAAAGACAAGGGAG) and 9~tl of water and sent to Genewiz
for sequencing using the "Difficult Template" settings and requesting "Protocol 5.1".
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acy-l (md1756) genotyping
acy-l-REV (CTCAAACGATGTCACACTGG) and acy-l-FWD
(TAACTCAAGTGCGACAGAGG)primers were used. The final PCR product size was
600 base pairs for the mutant band. Following PCR, gel electrophoresis was performed.
Gels, made of 1% agarose in TBE and one drop of ethidium bromide, were run with these
samples, and samples indicating mutant band sizes for acy-l were selected as they
represented a homozygote at that locus. To sequence, the DNA as run through a gel
purification kit (Qiagen). 5~tlof reverse diluted (5pmol/ul) primer
(CTCAAACGATGTCACACTGG) was added to l Ou! of purified DNA and was sent to
Genewiz.
Aldicarb Assay
Twelve aldicarb plates were made at a concentration of ImM aldicarb in NGM agar one
day before the experiment. Plates were poured and then left open for two hours to
solidify. After solidifying for two hours, the plates were spotted with OP50 E. coli and
left open for approximately one more hour to fully dry. They were then cover and left and
room temperature overnight. The next day, approximately 20 young adult worms were
picked to three plates per strain, with a total of 12 plates the day of the assay. Warms
were then plated from these 12 plates onto the experimental aldicarb plates in two-minute
time intervals. Every 20 minutes, the worms were tapped on the nose twice with a
platinum wire to determine if paralysis had occurred. Results were recorded every 20
minutes until two-thirds or more of the plates were completely paralyzed. The results
were graphed so that the average percentage of worm paralyzed at each timepoint ±
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s.e.m. was represented. There were five aldicarb assays performed to characterize acy-
lfshr-I phenotype.
Results
acy-l (gf),fshr-l double mutants were successfully generated and consistently
demonstrated a non-additive phenotype in aldicarb paralysis assays (Figure 3-1). This
indicates that acy-l andfshr-l are working in the same genetic pathway.
The double mutant gsa-l (gf),:fshr-l has not yet been generated due to many issues
obtaining a heterozygote during the crossing procedure. Difficulties obtaining the
heterozygote stemmed in large part from the need to use nested primers in addition to
requiring a more specific protocol when sequencing the difficult template DNA that
surrounds the ce81 point mutation.
Discussion
Results obtained from the a1dicarb behavioral assays indicate that the acy-
1(gf),:fshr-l double mutants show a non-additive phenotype, as these animals paralyze at
rates similar to that of the single mutant acy-l (gf) (Figure 3.1). These results indicate that
the adenylyl cyclase enzyme ACY -1 may work in the same signaling pathway as FSHR-l
to control muscle contraction. FSHR-l is known to be a GPCR and is activated by some
ligand, yet to be determined. However, our genetic data now support a model in which,
in neurons, FSHR-l activation in turn activates a cascade within the cell that uses the
enzymatic activity of ACY -1. These results are consistent with is what was seen in
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germline differentiation (Cho et al, 2007); thus, it is highly likely that FSHR-1 will also
be found to act through GSA-I, which also functions with FSHR-I in germline fate.
To further investigate the downstream pathway FSHR-1 activates, cell permeable
analogs of cyclic AMP, a product of the activation of adenylyl cyclase, can be used to
study the downward cascade in mutants lacking FSHR-1 protein. Iffshr-1 mutants that
are exposed to cell permeable analogs of cyclic AMP have muscle contraction similar to
gain of function acy-l mutants, we can more confidently say that FSHR-1 is working in
the same pathway as GSA-I and ACY -1 to promote muscle contraction at the NMJ.
Additionally, if the introduction of a cyclic AMP antagonist infshr-l mutants showed
similar muscle contraction to acy-l loss of function mutants, we could say that FSHR-1 is
working in the same pathway as GSA-I and ACY -1.
The double mutant gsa-l (gf) ,:fshr-l is still in the process of being generated due to issues
in priming and sequencing of the PCR products of the gene. Initially issues arose in
amplifying only the targeted segment of DNA, which included the point mutation. In
order to better specify this segment of DNA and decrease the amount of nonspecific
amplification, I used nested primers. The outer primers work to amplify a segment larger
than the original targeted DNA segment. This is then used as the template for a second
round of PCR, which uses inner primers to amplify a smaller section of DNA that
includes the point mutation. After using this technique, I was able to obtain more specific
bands on an agarose gel from which I could purify the DNA and send it for sequencing.
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Figure 3-1. acy-l (gf) ;fsIt r-L double mutants show non-additive effects in the aldicarb
assay. Average paralysis of four strains of C elegans for an aldicarb assay. N2 (wild
type) worms,fshr-l (ok77 8) mutants, acy-l (gj) mutants, and acy-l (gf) .fshr-l double
mutants were tested for paralysis in response to aldicarb. Worms were exposed to plates
containing 1mM aldicarb over a three hour time period. 20 young adult worms of each
strain (3 plates per strain) were tested for paralysis at time points taken every 25 minutes.
Error bars show the standard error of the mean.
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in order to identify heterozygotes versus homozygotes for the ce41 point mutation.
Currently my work on the gsa-I (gf),:f~hr-l cross is in the process of screening for gsa-
1(ce81) homozygotes among a series of/shr-l (ok778) homozygotes in the final stage. It
is essential to finish this cross to understand if gsa-I is a downstream target ofj~'hr-l as
we suspect now knowing acy-l is a downstream target of.fshr-l.
These results will provide information regarding the potential neuronal function
of FSHR-1, which may provide insight into human neurological diseases. Future
directions that can be taken after confirming the role of gsa-I in thefshr-l pathway might
include testing to see if FSHR-1 acts with other G protein pathways by again performing
double mutant analysis between.fshr-l and the following G-protein mutants: goa-L, gpa-
12, and egl-30 (Gaq pathway).
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Chapter 4: Regulation of Synaptic Vesicle localization by FSHR-l
Note of Clarification
The following experiments were performed by J. Kolnik. Continued work on the
imaging will be carried out by another labmate, A. Munneke. Strains were generated by
previous labmate Amy Wasilk.
Background
My previous behavioral assay data showed thatfshr-l single mutants have an
aldicarb-resistant phenotype (Figure 2-2), indicating thatfshr-l mutants have decreased
muscle contraction. The decreased muscle contraction could be due to decreased synaptic
vesicle release from cholinergic neurons at the NMJ, increased synaptic vesicle release
from GABAergic neurons, changes in acetylcholine or GABA receptors in the
postsynaptic muscle, or a combination of these effects.
Synaptobrevin (SNB-l) is an integral synaptic vesicle protein and is important in
determining the amount of signaling at a synapse due to its role in presynaptic neurons.
SNB-l tagged with green fluorescent protein (SNB-1::GFP) has been shown to localize
to presynapses of cholinergic neurons, where it appears in fluorescent puncta along the
dorsal nerve cord of SNB-l ::GFP-expressing animals (Sieburth et al , 2005). The
intensity, size, and density of these fluorescent puncta can be quantified and used as a
measure of the amount of synaptic vesicles present at neuromuscular synapses (Sieburth
et al, 2005). Previous studies using quantitative imaging of SNB-1::GFP at the C. elegans
NMJ have shown that a decrease in fluorescent puncta intensity generally indicates an
4·2
-
increase in synaptic vesicle release, as less synaptic vesicles are accumulating at the
synapse and the fluorescence of the exocytosed vesicles diffuses away from the synapse
(Dittman and Kaplan, 2006; Sieburth et al, 2005). Conversely, an increase in synaptic
SNB-l: :GFP fluorescence indicates an impaired release of synaptic vesicles that are stuck
in the presynapse (Sun et al, 2013). Additionally, a decrease in the number of SNB-
1::GFP puncta seen presynaptically in the dorsal nerve cord could possibly mean that
there is a decrease in the number of synapses, as it is known that SNB-1::GFP marks
presynaptic sites (Nonet 1999).
A previous large-scale screen reported that the synaptic puncta intensity of SNB-
l::GFP increases in cholinergic neurons in the dorsal nerve offshr-l mutants (Sieburth et
al. 2005).This can be attributed to an increased concentration of synaptic vesicles that are
not being released presynaptically. Though the screen by Sieburth et al (2005) identified
a role forfshr-l in regulating cholinergic synaptic vesicle release, given that.fi'hr-l has
broad expression in neurons and given our identification as a substrate of the APC, which
acts in GABA neurons to control NMJ function, it is also possible that loss of.f~'hr-l
impacts GABA synaptic release.
Thus, to confirm the results of the Sieburth et al (2005) screen in acetylcholine
motor neurons and to test for additional roles forfshr-l in reference to GABA release, I
performed imaging experiments to quantify synaptic levels of SNB-l::GFP in motor
neurons. To do this, I used nuIsl52 worms, which express SNB-l ::GFP under a
cholinergic motor neuron promoter (Punc-129) andjulsl worms, which express SNB-
1::GFP under a GABAergic promoter (Punc-25) (Sieburth et al. 2005; Jin et al. 1999).
Each strain marks either the cholinergic synaptic vesicles with GFP or the GABAergic
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synaptic vesicles with GFP, respectively. Given the reduced muscle contraction in
animals lackingjshr-l, I hypothesized that there will be a greater SNB-l::GFP puncta
intensity in the acetylcholine neurons ofJshr-l mutants and a decrease SNB-l: :GFP
puncta intensity in GABA neurons offshr-l mutants.
Methods and Materials
C. elegans strain maintenance
Strains used in this experiment included N2 (Bristol) wild-type,juIsl ,juisl ,fshr-
1(ok778), nuIs152, nuIs152,fshr-l(ok778). All of the strains were maintained following
protocols by (Brenner 1974).
Imaging Protocol
Images of the dorsal nerve cord posterior to the vulva of the SNB-l ::GFP-expressing
worms were taken. When imaging, 15-20 young adult worms were picked onto glass
coverslips with 30mg/mL 2,3-Butandedione monoxime (Sigma-Aldrich) to temporarily
paralyze the worms. Next a 2% agarose (Sigma-Aldrich) in water mixture was used to
make pads on slides. After allowing the worms to paralyze for 5 minutes, each slide was
f1ipped onto a glass coverslip containing the worms. Images were taken using a Leica
DMLB compound f1uorescent microscope set to a magnification of lOOxand images
were taken on Exi Aquia cooled CCD camera Q Imaging using Metamorph (v 7.7)
software (Molecular Devices).
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Image Quant(fication
For quantitative analyses of f1uorescent puncta of the dorsal nerve cord, maximum
intensity projections of Z series stacks (lurn total depth) were made. The exposure
settings and gain were set to fill a 12-bit dynamic range. These settings were the same for
all images taken. After images were taken, the intensity, size, and density of the SNB-
l::GFP fluorescent puncta from each dorsal nerve cord, as well as the inter-punctal
axonal fluorescence was quantified using linescans performed with Metamorph 7.1
software (Molecular Devices) and linescan analysis done with custom-written Igor Pro
(Wavemetrics) program (Burbea, et al, 2002). Mercury arc lamp output was normalized
by measuring the intensities of 0.5 urn FluoSphere beads (Invitrogen) for each imaging
day. The puncta intensities were calculated by dividing the average maximal peak
intensity by the average bead intensity for the corresponding day. Inter-punctal axonal
intensities were similarly calculated using the average baseline fluorescence value within
the dorsal nerve cord. Puncta densities were determined by quantifying the average
number of puncta per 10 urn of the dorsal nerve cord. For all data collected, an average of
the values for each worm in the data set ± s.e.m. is shown. Statistical significance of any
differences between wild-type and mutant values was determined using the Student's t
test (p ~ 0.05). Graphs of the puncta intensities and inter-punctal axonal fluorescence
show data normalized to wild-type (nuIsI52) values.
Results
Analysis of dorsal nerve cord images of synaptic vesicles revealed that nuIs152,fshr-l
mutant animals had a 31% increase in SNB-1: :GFP puncta intensity compared to wild-
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type worms (Figure 4-1), indicating a buildup of synaptic vesicles due to an inhibition in
the release in presynaptic acetylcholine motor neurons. Intra axonal cord fluorescence
intensity also increased, but not significantly. There were no changes in the width or
density of synapses indicating no change in the number of synapses between mutant and
wild-type (Figure 4-1).
Discussion
Our results indicate that nuIs152,fshr-l animals show an increased intensity of
SNB-l::GFP puncta in cholinergic neurons of the dorsal nerve cord (Figure 4.1). This
indicates a build-up of synaptic vesicles in the presynaptic neurons, which may be due to
the inability of these neurons to release the synaptic vesicles. This is consistent with the
findings previously reported by Sieburth et al (2005) and with the aldicarb- resistant
phenotype indicative of decreased muscle contraction seen infshr-l mutants. Thus,
FSHR-l could be playing a role in promoting the proper release of synaptic vesicles.
Such a decrease in acetylcholine release likely explains in all or part the decreased
muscle contraction infshr-l loss of function animals; to test if GABA signaling is also
being affected inj~'hr-l mutants, I will be imagingjulsl,:fs'hr-l mutants to quantify SNB-
1::GFP at presynaptic GABA neurons.julsl .fshr-I animal have yet to be tested, and no
previous research has been done on this strain.
In the future it would be helpful to look at possible indirect effects on presynaptic
proteins and receptors caused by [shr-I loss of function. To look at these possible effects,
I could fluorescently tag other known presynaptic proteins and/or receptors and image
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Figure 4-1. FSHR-lloss of function mutants have increased synaptic SNB-l::GFP
fluorescence in acetylcholine neurons in the dorsal nerve cord. (A) Representative
images ofSNB-l::GFP in motor neurons (nuIs152) of the dorsal nerve cord of wild-type
andfshr-l (ok778) mutants (1OOx).(B) Quantification of SNB-l ::GFP puncta intensity,
inter-punctal f1uorescence intensity, density, and width for strains in (A) ± s.e.m. (n=19).
(*p<O.05)
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their localization in wild type andfshr-l mutant animals. Finally, future experiments
looking at electrophysiology in the postsynaptic muscle cell are needed to compare the
excitatory and inhibitory electrical input infshr-l mutants versus wild-type animals.
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Chapter 5: Conclusions and Future Directions
Finding ways to treat and possibly cure neurological diseases such as Parkinson's
or Alzheimer's is critical today as many people are faced with diagnoses of these
diseases. In hopes of making progress, work in understanding the regulatory mechanisms
and pathways that control our nervous system is necessary, Specifically I want to
understand how GPCRs control the nervous system through modulating neurotransmitter
signaling, and possibly interacting with neuropeptide pathways, at NMJ synapses. Here,
the goal of my project was to investigate the role of FSHR-1, a GPCR, at the NMJ.
Specifically, I set out to use behavioral assays and genetic and imaging approaches to
elucidate the upstream and downstream pathways FSHR-1 may utilize to control muscle
contraction in C. elegans
The initial results found in behavioral assays targeted at understanding the role
FSHR -1 plays in neuropeptide signaling indicate that FSHR -1 does not have a role in
neuropeptide regulation. EGL-21 is a known neuropeptide processing enzyme (Jacob and
Kaplan, 2003) that, like FSHR-l, promotes muscle contraction, and thus was
hypothesized to be involved in FSHR-l signaling. However, the non-additive results seen
in egl-21,fshr-l behavioral assays indicate that egl-21 andfshr-l act in separate pathways
at the NMJ (Figure 2-2). The neuropeptide processing enzyme EGL-3 is known to work
on a different class of neuropeptides (Jacob and Kaplan, 2003); thus, to completely rule
out an interaction between FSHR-l and neuropeptide pathways, both an egl-3,:fshr-1
double mutant and a egl-3;egl-21 .fshr-I triple mutant need to be generated and NMJ
behavioral assays performed. The phenotype that is observed in these mutants, in which
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a broader range of neuropeptide processing enzymes will be knocked out, will provide a
better understanding of what role, if any, FSHR-l plays in neuropeptide signaling at the
NMJ.
My data thus far indicate that FSHR-l and the downstream signaling enzyme
adenylyl cyclase (ACY -1), act in the same signaling pathway to control NMJ function, as
behavioral assays performed on thej~'hr-l;acy-l (g/) double mutants show a non-additive
phenotype that resembles that of single acy-l gain of function mutants (Figure 2-1). This
is indeed interesting as gsa-I should also be working in the same genetic pathway esfshr-
1 and acy-l. In the near future, I hope to successfully generate the gsa-l.fshr-I double
mutant so that I may confirm a non-additive phenotype, like acy-Ifshr-I double mutant,
to conclusively say that FSHR-1 is the GPCR that is activating this Gas pathway in
which GSA-l and ACY -1 are acting, as seen in germline differentiation (Cho et al 2007).
Future studies to furthering our understanding of the downstream signaling pathway
might be looking at creating mutants of downstream signaling molecules or using cell
permeable analogs and identifying their roles in the pathway.
Knowing the aldicarb-resistant phenotype offshr-l mutants in aldicarb assays for
NMJ function, it was necessary to understand why there was reduced muscle contraction
at the NMJ. To investigate this, imaging of synaptic vesicles in cholinergic and
GABAergic presynaptic neurons at the NMJ was performed. Results of imaging
nuls152;fshr-l indicate SNB-l ::GFP synaptic vesicle t1uorescence intensity is increased
in cholinergic motor neurons at the NMJ (Figure 4.1), indicating a build-up of synaptic
vesicles in the presynaptic cholinergic neurons oifshr-I mutants compared to wild type
worms. These data suggest that these acetylcholine-containing presynaptic vesicles are
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not being released, which is consistent with the aldicarb-resistant phenotype displayed
during behavioral assays offshr-l mutants. These preliminary results may not be the
whole story, however, as GABAergic motor neurons have yet to be imaged and the SNB-
I ::GFP puncta quantified. Increased GABA signaling, or a reduction in fluorescence
intensity or increase in number of GABAergic synapses, would also contribute to the
resistant phenotype observed infshr-l mutants.
Future directions other labmates are investigating include looking in APC mutants
and see if FSHR-l levels are changing. This would be done through fluorescently tagging
FSHR-l and imaging where it localizes. Additionally, we are interested in investigating
where expression of FSHR-l, in cholinergic or GABAergic neurons, is sufficient to
restore normal muscle contraction infshr-l mutants.
The work already completed here and the additional proposed investigations are
relevant as many mechanisms, pathways, and molecular components of the worm system
are conserved in mammals. Thus by better understanding these systems in their simplicity
within the worm model, we may better understand the mechanisms and pathways that
homologues of these molecular components are regulating in humans. Specifically it is
important to understand how FSHR-l, a GPCR, is affecting neuronal signaling and
ultimately muscle contraction in the worm model as GPCRs are targets for over 50% of
medicines. Once we better understand how our human nervous system works we can
begin finding ways to treat many neurological diseases.
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Appendix 1: Investigating if FSHR-l expression in neurons is sufficient
for normal NMJ transmission
Note of Clarification
The following experiments were performed by J. Kolnik as a follow-up to work begun by
a former research student A. Wasilk. Thefshr-l neuronal rescue strain (AU209 [Pric-
19:.f~·hr-l;fshr-l (ok778)]) was obtained from Dr. Jennifer Powell (Gettysburg College).
Background
The balance of excitatory cholinergic and inhibitory GABAergic signaling is
essential for normal neuronal signaling and control of muscle contraction. Neuronal
signaling can be assessed through measuring muscle contraction in aldicarb behavioral
assays. Here, aldicarb inhibits acetylcholinesterase, which is known to break down
acetylcholine in the synaptic cleft, therefore causing a build-up of acetylcholine leading
to constant excitatory signaling and eventually hyper-contraction and paralysis.
fshr-l was initially researched due to the fact that it was identified in a recent
screen as an aldicarb-resistant gene (Sieburth et al, 2005) and also has Anaphase
Promoting Complex recognition motifs, therefore making it a good candidate as an APC
substrate important at the NMJ. A previous labmate, A. Wasilk, performed several rescue
experiments in which she expressedfshr-l under a panneuronal promoter in wild-type
and fshr-l mutants. The goal of these rescue experiments was to determine if re-
expressing.f~'hr-l under a panneuronal promotor is sufficient for restoration of a wild-
type phenotype due to high.f~'hr-l expression in neurons. After several aldicarb assays
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performed by A. Wasilk, the phenotype was not clearly characterized, so my goal was to
replicate the aldicarb assays to definitively characterize the phenotype of the neuronally
rescued fshr-I animals.
Methods and Materials
C elegans strain Maintenance
The following strains were used: N2 (Bristol) wild type,Jshr-1 (0k778) and
AU209 [Pric-19::FSHR-l;fshr-l (ok778)]. All strains were maintained on NGM agar
plates with OP50 E. coli as a food source according to the protocols by (Brenner 1974).
Aldicarb Assay
Twelve aldicarb plates were made at a concentration of 1mM aldicarb in NGM
agar one day before the experiment. Plates were poured and left open for two hours at
room temperature to solidify, then spotted with OP50 E. coli and left open for
approximately one more hour to fully dry. Plates were then covered and left at room
temperature overnight. The next day, approximately 20 young adult worms were picked,
under a fluorescent microscope, to each of three plates per strain, with a total of 9 plates
the day of the assay. Warms were then plated from these 9 plates onto the experimental
aldicarb plates in two-minute time intervals. Beginning 40 minutes after plating, the
warms were tapped on the nose twice with a platinum wire every 20 minutes to
determine if paralysis had occurred. Results were recorded every 20 minutes until two-
thirds or more of the plates were completely paralyzed. The results were graphed so that
the average percentage of worms paralyzed ± s.e.m. at each timepoint was represented.
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Results
Two behavioral assays were performed to assess the phenotype of the fshr-I panneuronal
rescue strain. A wild-type aldicarb phenotype was observed for the rescued worms when
compared to N2 andfshr-l mutants (Figure A-I), indicating that NMJ synaptic function
had been restored in these animals.
Discussion
The results obtained here with AU209 strain, which rescuesfshr-l only in neuronal cells
of the fshr-I mutants, indicate a wild-type phenotype in aldicarb assays meaning that
fshr-I expression in neurons is sufficient for the restoration of normal NMJ synaptic
transmission. This is what Amy previously found in some of her aldicarb assays, which
indicates FSHR-1 expression in neurons is sufficient to restore normal muscle
contractions. Next, a fellow labmate A. Munneke is going to be looking at neuronal-
specific expression of FSHR -1 in exclusively cholinergic or GABAergic neurons to
determine in which, or both, the expression of FSHR-I is sufficient to rescue a wild-type
aldicarb phenotype.
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Figure A-I. AU209 panneuronal rescue animals display wild-type phenotype in the
aldicarb assay . Average paralysis of four strains of C elegans for an aldicarb assay. N2
(wild type) worms,fshr-l(ok778) mutants, AU209 were tested for paralysis in response
to aldicarb. Worms were exposed to plates containing ImM aldicarb over a three hour
time period. 20 young adult worms of each strain (3 plates per strain) were tested for
paralysis at time points taken every 20 minutes. Error bars show the standard error of the
mean.
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